» Authors » Matthias Doring

Matthias Doring

Explore the profile of Matthias Doring including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 823
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Berzow D, Descamps D, Obermeier M, Charpentier C, Kaiser R, Guertler L, et al.
Clin Infect Dis . 2020 Apr; 72(3):503-509. PMID: 32227124
Human immunodeficiency virus-2 (HIV-2) is endemic in some countries in West Africa. Due to the lower prevalence in industrialized countries, there is limited experience and knowledge on the management of...
2.
Kreer C, Doring M, Lehnen N, Ercanoglu M, Gieselmann L, Luca D, et al.
J Immunol Methods . 2020 Jan; 480:112752. PMID: 31991148
To study the diversity of immune receptors and pathogens, multiplex PCR has become a central approach in research and diagnostics. However, insufficient primer design against highly diverse templates often prevents...
3.
De Luca A, Pezzotti P, Boucher C, Doring M, Incardona F, Kaiser R, et al.
PLoS One . 2019 Nov; 14(11):e0225381. PMID: 31751385
Objectives: The study aimed to survey maraviroc use and assess effectiveness and durability of maraviroc-containing antiretroviral treatment (ART) in routine practice across Europe. Methods: Data were retrieved from 26 cohorts...
4.
Doring M, Kreer C, Lehnen N, Klein F, Pfeifer N
Sci Rep . 2019 Jul; 9(1):10748. PMID: 31341211
Successful primer design for polymerase chain reaction (PCR) hinges on the ability to identify primers that efficiently amplify template sequences. Here, we generated a novel Taq PCR data set that...
5.
Doring M, Buch J, Friedrich G, Pironti A, Kalaghatgi P, Knops E, et al.
Nucleic Acids Res . 2018 May; 46(W1):W271-W277. PMID: 29718426
Identifying resistance to antiretroviral drugs is crucial for ensuring the successful treatment of patients infected with viruses such as human immunodeficiency virus (HIV) or hepatitis C virus (HCV). In contrast...
6.
Doring M, Borrego P, Buch J, Martins A, Friedrich G, Camacho R, et al.
Retrovirology . 2016 Dec; 13(1):85. PMID: 27998283
Background: CCR5-coreceptor antagonists can be used for treating HIV-2 infected individuals. Before initiating treatment with coreceptor antagonists, viral coreceptor usage should be determined to ensure that the virus can use...
7.
Kartashev V, Doring M, Nieto L, Coletta E, Kaiser R, Sierra S
J Clin Virol . 2016 Jul; 81:82-9. PMID: 27367545
Background: HCV affects 185 million people worldwide and leads to death and morbidities. HCV has a high genetic diversity and is classified into seven genotypes and 67 subtypes. Novel anti-HCV...
8.
Peiffer K, Sommer L, Susser S, Vermehren J, Herrmann E, Doring M, et al.
Hepatology . 2015 Sep; 63(1):63-73. PMID: 26406534
Unlabelled: Single-nucleotide polymorphisms (SNPs) in the interferon lambda 4 (IFNL4) gene are predictors for treatment success in patients with hepatitis C virus (HCV) infection. For direct-acting antiviral combinations only weak...
9.
Nogales A, Nobre T, Valadas V, Ragonezi C, Doring M, Polidoros A, et al.
Brief Funct Genomics . 2015 Aug; 15(4):288-97. PMID: 26293603
Molecular plant breeding usually overlooks the genetic variability that arises from the association of plants with endophytic microorganisms, when looking at agronomic interesting target traits. This source of variability can...
10.
Hardoim P, S van Overbeek L, Berg G, Pirttila A, Compant S, Campisano A, et al.
Microbiol Mol Biol Rev . 2015 Jul; 79(3):293-320. PMID: 26136581
All plants are inhabited internally by diverse microbial communities comprising bacterial, archaeal, fungal, and protistic taxa. These microorganisms showing endophytic lifestyles play crucial roles in plant development, growth, fitness, and...